reformulation of known drugs

Double Bond Pharmaceutical is a pharmaceutical company founded in 2014 by Dr. Igor Lokot that develops and commercializes innovative first-in-class treatments for cancers and infectious diseases. It focuses on redeveloping known drugs by changing the route of administration to create new formulations that reduce side effects and improve efficacy, with expertise in brain cancer, liver cancer and pneumonia.

Read more

AI-driven drug discoveryclinical researchdrug delivery systemsdrug development